Release Date: 30/12/22 10:19 Summary: Notice of General Meeting/Proxy Form Price Sensitive: No Download Document 473.42KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%